Pharmaceutical plant, which will be builtby PSK Pharma resident company in Moscow Region special economic zone "Dubna", will be the only one in Russia in terms of equipment level and applied innovative technologies. Its total area is 9,000 square meters, and the investment in the project will exceed a billion rubles. The resident plans to commission the first stage of the object already at the end of this year, the start of medicines production is planned for May 2018.
В В В В
Detailed information about the project was told by Olga Turchaninova, Director of LLC“PSK Pharma” at the solemn ceremony dedicated to the beginning of the work. She explained that the plant will produce vital medicines, and emphasized the exclusivity of the future enterprise: "The technologies that we bring here using the world experience are unique. The production of a wide range of medicinal forms for the treatment of asthma and chronic obstructive pulmonary diseases will be established here. In addition, the plant plans to develop and exploit biotechnology - a completely new topic for Russia, and we are ready to do this ".
В
At the first stage, with one-shift work, the resident intends to create more than 130 workplaces. But ifthere will be a need to increase production volume when the enterprise reaches full capacity, the company is ready to increase the number of specialists to 250. Only professionals can work at such factory. Therefore, it was no accident that the site of the SEZ in the science city of Dubna was chosen for its localization. So thinks the initiator of the project, the president of LLC“Rus Biopharm” and the founder of LLC“PSK Pharma” - the company with the Indian capital Punia Satia Karm: "We make a lot of investments in the project, and we will produce vital drugs. Therefore, it is important for us that the plant is being built in Russia, and exactly in Dubna. I heard only positive comments about the special economic zone. I’m very glad that I have a team that can meet this challenge and I hope that we will receive support here”.
В
Anton Afanasyev, General Director of JSC "SEZ TIT “Dubna", confirmed – there will be support: "The company became a resident only last year, has already entered the construction site, and promises to start production in a year - we are always glad to have such active investors! The announced figures for the implementation of the project are very attractive. "PSK Pharma" is another anchor resident of special economic zone "Dubna". On behalf of the Management Company team, I want to assure the investor that he can always count on our help”.
В
Regional government leaders will also readily support the implementation of such a large, socially significant project. On behalf of them "PSK Pharma" was congratulated by Victoria Halimendik, the head of the Innovation Infrastructure Department of Innovative and Scientific Policy Office. She again reminded about preferences for residents of SEZ "Dubna" and noted that the investor made the right choice in favor of localizing the company in Moscow Region.
В
Today in "PSK Pharma" portfolio there are 30 titles of products, the release of which the resident intends to begin already in May 2018. So exactly in a year on the left-bank site of SEZ "Dubna" white construction helmets will be replaced by white sterile dressing gowns, and the new enterprise will start manufacturing medical products necessary for our country.